Found: 235
Select item for more details and to access through your institution.
Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 1, p. 80
- By:
- Publication type:
- Article
Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 3, p. 472, doi. 10.1093/jac/dki481
- By:
- Publication type:
- Article
Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 5, p. 847, doi. 10.1093/jac/dki328
- By:
- Publication type:
- Article
New inhibitors of human cytomegalovirus (HCMV) on the horizon.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1079, doi. 10.1093/jac/dkg205
- By:
- Publication type:
- Article
The design of drugs for HIV and HCV.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 12, p. 1001, doi. 10.1038/nrd2424
- By:
- Publication type:
- Article
Three decades of antiviral drugs.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Antiviral agents active against influenza A viruses.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Case history: Acyclic nucleoside phosphonates: a key class of antiviral drugs.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 11, p. 928, doi. 10.1038/nrd1877
- By:
- Publication type:
- Article
The bicyclam AMD3100 story.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Timeline: The bicyclam AMD3100 story.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 7, p. 581, doi. 10.1038/nrd1134
- By:
- Publication type:
- Article
STRATEGIES IN THE DESIGN OF ANTIVIRAL DRUGS.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 1, p. 13, doi. 10.1038/nrd703
- By:
- Publication type:
- Article
Current treatment of hepatitis B virus infections.
- Published in:
- Reviews in Medical Virology, 2015, v. 25, n. 6, p. 354, doi. 10.1002/rmv.1849
- By:
- Publication type:
- Article
Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.
- Published in:
- Reviews in Medical Virology, 2015, v. 25, n. 4, p. 254, doi. 10.1002/rmv.1842
- By:
- Publication type:
- Article
The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
- Published in:
- Reviews in Medical Virology, 2012, v. 22, n. 6, p. 392, doi. 10.1002/rmv.1727
- By:
- Publication type:
- Article
The history of antiretrovirals: key discoveries over the past 25 years.
- Published in:
- Reviews in Medical Virology, 2009, v. 19, n. 5, p. 287, doi. 10.1002/rmv.624
- By:
- Publication type:
- Article
Clinical features and treatment of adenovirus infections.
- Published in:
- Reviews in Medical Virology, 2008, v. 18, n. 6, p. 357, doi. 10.1002/rmv.589
- By:
- Publication type:
- Article
Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.
- Published in:
- Reviews in Medical Virology, 2008, v. 18, n. 1, p. 19, doi. 10.1002/rmv.554
- By:
- Publication type:
- Article
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections.
- Published in:
- Reviews in Medical Virology, 2004, v. 14, n. 5, p. 289, doi. 10.1002/rmv.439
- By:
- Publication type:
- Article
Design and synthesis of Fsp<sup>3</sup>‐enriched spirocyclic‐substituted diarylpyrimidine derivatives as novel HIV‐1 NNRTIs.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 3, p. 1, doi. 10.1111/cbdd.14510
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity.
- Published in:
- Chemical Biology & Drug Design, 2021, v. 97, n. 1, p. 67, doi. 10.1111/cbdd.13760
- By:
- Publication type:
- Article
Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV‐1 RNase H inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 93, n. 4, p. 582, doi. 10.1111/cbdd.13455
- By:
- Publication type:
- Article
Discovery of potent HIV‐1 non‐nucleoside reverse transcriptase inhibitors by exploring the structure–activity relationship of solvent‐exposed regions I.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 93, n. 4, p. 430, doi. 10.1111/cbdd.13429
- By:
- Publication type:
- Article
Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 6, p. 2009, doi. 10.1111/cbdd.13373
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 88, n. 3, p. 380, doi. 10.1111/cbdd.12765
- By:
- Publication type:
- Article
Arylazolyl(azinyl)thioacetanilides: Part 19.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 88, n. 2, p. 241, doi. 10.1111/cbdd.12751
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential Anti- HIV-1 Agents.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 87, n. 2, p. 283, doi. 10.1111/cbdd.12657
- By:
- Publication type:
- Article
Synthesis and Preliminary Antiviral Activities of Piperidine-substituted Purines against HIV and Influenza A/H1N1 Infections.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 4, p. 568, doi. 10.1111/cbdd.12520
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1 H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3 H)-one As Potential HIV-1 Inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 4, p. 614, doi. 10.1111/cbdd.12524
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of Novel Benzoyl Diarylamine/ether Derivatives as Potential Anti-HIV-1 Agents.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 3, p. 333, doi. 10.1111/cbdd.12497
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of Novel 4-Aminopiperidinyl-linked 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 1, p. 887, doi. 10.1111/cbdd.12468
- By:
- Publication type:
- Article
Design, Synthesis, and Anti- HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 1, p. 902, doi. 10.1111/cbdd.12471
- By:
- Publication type:
- Article
Synthesis and Anti- HIV Activity of 4-(Naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl Derivatives.
- Published in:
- Chemical Biology & Drug Design, 2014, v. 84, n. 4, p. 420, doi. 10.1111/cbdd.12328
- By:
- Publication type:
- Article
Synthesis and Preliminary Biologic Evaluation of 5-Substituted-2-(4-substituted phenyl)-1,3-Benzoxazoles as A Novel Class of Influenza Virus A Inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2012, v. 79, n. 6, p. 1018, doi. 10.1111/j.1747-0285.2012.01344.x
- By:
- Publication type:
- Article
Discovery of Dihydro-Alkyloxy-Benzyl-Oxopyrimidines as Promising Anti-Influenza Virus Agents.
- Published in:
- Chemical Biology & Drug Design, 2011, v. 78, n. 4, p. 596, doi. 10.1111/j.1747-0285.2011.01180.x
- By:
- Publication type:
- Article
Cytostatic and Antiviral Activity Evaluations of Hydroxamic Derivatives of Some Non-steroidal Anti-inflammatory Drugs.
- Published in:
- Chemical Biology & Drug Design, 2009, v. 73, n. 3, p. 328, doi. 10.1111/j.1747-0285.2009.00774.x
- By:
- Publication type:
- Article
Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1215, doi. 10.3390/ijms24021215
- By:
- Publication type:
- Article
3′-(1,2,3-Triazol-1-yl)-2′,3′-dideoxythymidine and 3′-(1,2,3-triazol-1-yl)-2′,3′-dideoxyuridine.
- Published in:
- Journal of Heterocyclic Chemistry, 1989, v. 26, n. 6, p. 1635, doi. 10.1002/jhet.5570260624
- By:
- Publication type:
- Article
Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 8, p. 1, doi. 10.1002/jmv.29830
- By:
- Publication type:
- Article
Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 4, p. 1, doi. 10.1002/jmv.29594
- By:
- Publication type:
- Article
Structure‐based design of diarylpyrimidines and triarylpyrimidines as potent HIV‐1 NNRTIs with improved metabolic stability and drug resistance profiles.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 3, p. 1, doi. 10.1002/jmv.29502
- By:
- Publication type:
- Article
Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 3, p. 1, doi. 10.1002/jmv.28635
- By:
- Publication type:
- Article
Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28340
- By:
- Publication type:
- Article
Discovery of novel 1,2,4‐triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 12, p. 5975, doi. 10.1002/jmv.28064
- By:
- Publication type:
- Article
Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.
- Published in:
- Journal of Medical Virology, 2005, v. 75, n. 2, p. 332
- By:
- Publication type:
- Article
Inhibition of coxsackie B3 virus induced myocarditis in mice by 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile.
- Published in:
- Journal of Medical Virology, 2004, v. 72, n. 2, p. 263
- By:
- Publication type:
- Article
Chromosome 21 does not code for an interferon receptor.
- Published in:
- Nature, 1976, v. 264, n. 5583, p. 249, doi. 10.1038/264249a0
- By:
- Publication type:
- Article
Non-antiviral activities of interferon are not controlled by chromosome 21.
- Published in:
- Nature, 1975, v. 256, n. 5513, p. 132, doi. 10.1038/256132a0
- By:
- Publication type:
- Article
Vesicular stomatitis virus (VSV) as a paradigm for predicting antiviral activity against Ebola virus (EBOV).
- Published in:
- Marmara Pharmaceutical Journal, 2015, v. 19, n. 2, p. 141, doi. 10.12991/mpj.20151910461
- By:
- Publication type:
- Article
Synthesis and biological evaluation of some new 1,3,4-thiadiazole and 1,2,4-triazole derivatives from L-methionine as antituberculosis and antiviral agents.
- Published in:
- Marmara Pharmaceutical Journal, 2015, v. 19, n. 2, p. 88, doi. 10.12991/mpj.2015199639
- By:
- Publication type:
- Article
Synthesis and evaluation of antiviral, antitubercular and anticancer activities of some novel thioureas derived from 4-aminobenzohydrazide hydrazones.
- Published in:
- Marmara Pharmaceutical Journal, 2010, v. 14, n. 1, p. 13
- By:
- Publication type:
- Article